Research Grants

No.

Sponsor Grant no. (period)

Title

Total amount*

Total amount for Hassan Lab (and UMSOP collaborators)

Principle Investigator(s) (PI)

Role of Dr. Hassan

13

NIH RTOP_Contract Numbers: HHSN272201300015I – HHSN272201300023 Task Order Request – TASK ORDER FY.2017.B2C2D2.0053 (16-0075) – (2016 – 2019)

A Population Pharmacokinetic Study to Evaluate the Dose Need to Achieve Vancomycin AUC/MIC >400 in Critically-Ill Pediatric Patients

TBD

TBD

Jim Campbell

KP

12

NIAID/NIH 1R01AI123820-01 (09/2016-08/2020)

Protection Against Gram Negative Sepsis Conferred by Lipid A Based Structural Variants

$1,540,836

$240,240

Robert Ernst

KP

11

FDA/NIPTE-UO1-MD-2016-003 (prime award # 5UO1FD004275-05)(03/2016–02/2017)

Identification of chemical enhancer specification requirements for TDDS

$528,811

$528,811

Audra Stinchcomb, Hazem Hassan

   PI

(MPI Grant)

10

FDA/NIPTE-UO1-MD-2015-001 revised(prime award # 5UO1FD004275-04)(01/2016–01/2017)

Absolute Bioavailability/PK and Residual Drug analysis of Fentanyl Transdermal Systems in Healthy Adults

$120,000

$120,000

Audra Stinchcomb, Hazem Hassan

   PI

(MPI Grant)

Supplement

9

Maryland Innovation Initiative(08/2015–06/2016)

Novel Multi-Target Antimicrobials of Heme utilization in P. aeruginosa

$100,000

$2,500

Angela Wilks

   KP

8

FDA/NIPTE-UO1-MD-2015-001 (prime award # 5UO1FD004275-04)(01/2015–01/2016)

Absolute Bioavailability/PK and Residual Drug analysis of Fentanyl Transdermal Systems in Healthy Adults

$864,000

$864,000

Hazem Hassan,  Audra Stinchcomb

   PI

(MPI Grant)

7

FDA  U01FD004955 (09/2013 -08/2018)

Heat Effect on Generic Transdermal Drug Delivery Systems

$1,999,996

$1,999,996

Hazem Hassan,  Audra Stinchcomb

   PI

(MPI Grant)

6

FDA U01FD004955-01S1

Heat Effect on Generic Transdermal Drug Delivery Systems (Bioavailability Evaluation of contraceptive transdermal drug delivery systems)

$699,999

$699,999

Audra Stinchcomb,  Hazem Hassan

   PI

(MPI Grant)

(09/2014 -08/2015)

Supplement

5

FDA U01FD004947 09/2013 -08/2018)

Bioequivalence of topical drug products: in vitro – in vivo correlations

$2,499,989

$2,499,989

Audra Stinchcomb, Hazem Hassan, Steve Hoag,

   PI

(MPI Grant)

4

NICHD/NIH R01HD067126 (03/2011 – 02/2016)

Azithromycin to prevent BPD in Ureaplasma-infected preterm neonates

$2,971,701

$50,000

Rose Viscardi

   KP

3

NIDA/NIH 5DP1DA031401 (09/2010 – 11/2015)

Development of l-THP as new medication for drug addiction

$3,558,615

$200,000

Jia Bei Wang

   KP

2

NIA/NIH 5R01AG037120-03 (08/2011 – 05/2017)

Non-Invasive treatment of abdominal aortic aneurism clinical trial (N-TA^3CT)

$3,598,127

$229,000

Michael Terrin

   KP

1

NCCAM/NIH 5R01AT00689903 (Subcontract_2015)

Mechanism of action of L-THP as an alternative therapy for cocaine addiction

$9,409

$9,409

Liu-Chen

Subaward PI

Total

$16,921,836

$7,174,893

Pending Research Grant

1

Purdue University Subcontract/NIH Prime Hassan (09/2014 – 08/2019)

Brain-Penetrating GABA-B Agonists for Alcohol Dependence

$482,127

$482,127

David Colby

Subaward PI

Completed Research Grant

1

NIDA/NIH 5R01DA016715-05 (2009 – 2010)

Benzotropine analogs as cocaine abuse pharmacotherapies

$40,000

$40,000

Natalie Eddington

   KP

*some numbers are rounded

PI: Principal investigator;  KP: Key Personnel; MPI: Multi-Principal Investigators